Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen, Regeneron May Yet Get Rich From Their Cholesterol Drugs
Amgen, Regeneron May Yet Get Rich From Their Cholesterol Drugs
Amgen, Regeneron May Yet Get Rich From Their Cholesterol Drugs
Submitted by
admin
on December 20, 2016 - 12:04pm
Source:
Seeking Alpha
News Tags:
Amgen
Regeneron
Praluent
Repatha
Sanofi
Headline:
Amgen, Regeneron May Yet Get Rich From Their Cholesterol Drugs
Do Not Allow Advertisers to Use My Personal information
